Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
about
Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsmiR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseTherapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.MicroRNA-155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resectionTargeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.MicroRNA: an important regulator in acute myeloid leukemia.Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia.Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML.Protein neddylation and its alterations in human cancers for targeted therapy.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation.miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development.miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways.Enhancer control of miR-155 expression in Epstein-Barr virus infected B cells
P2860
Q28071427-7679BC80-5AC4-4790-9950-BEBBE7BE5208Q33782332-41352501-B01E-42D3-B860-F8633E676B95Q33792598-760A2A05-FA9A-41C6-9F05-60EC64AEEA93Q36493057-140D6527-565A-4CA9-A0BF-2F6F737EDB4BQ37644854-3F04A083-C590-4BC8-8C6B-547C81372F4EQ37662370-9A655869-A45F-49E8-8201-F8AB4EFCB819Q37737112-79B2EB28-41C3-4D73-B02D-E715B6615A42Q38430180-DCBAC929-70C7-46B1-8D4E-CA59E7FA0CF3Q38735859-FC08078E-431D-4B4B-96F3-4C29D3FE9F8EQ39292054-1F184DE2-9089-486D-B5D4-B605F580F910Q41991525-A26CBA07-53FF-4C4A-8E9E-895C812BA148Q47307310-54E7BC4C-30CA-46A9-A0F6-8B1CACA4F009Q47347914-92D58AD8-67B8-4E00-9E42-C346F707BAABQ48104779-F9955A89-AF83-4583-916D-7170DBB07C58Q48216923-39D4527A-7CD6-432D-85B6-97C308AD2A0CQ48538797-DF54CE82-5D64-4ACB-8FC0-3E1FC7C0233BQ49544999-3B641ED7-7104-4355-BA38-3DE65607DE9CQ50157930-ED272A97-9181-42BD-A455-04DEC261B686Q52587340-29349775-5EB4-41F9-A62E-FB8C61959FD8Q55368106-90D4FAC7-6E3E-460D-A9DD-52F0EEE221B9Q58746075-1A07604B-5EE0-45AE-8D16-03C4B61781C5
P2860
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@ast
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@en
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924
@nl
type
label
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@ast
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@en
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924
@nl
prefLabel
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@ast
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@en
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924
@nl
P2093
P2860
P356
P1433
P1476
Pharmacological targeting of m ...... T3-ITD acute myeloid leukemia.
@en
P2093
A Dorrance
B C Medeiros
D Perrotti
F Pichiorri
G Marcucci
H Alachkar
H S Radomska
J H Mendler
P2860
P2888
P304
P356
10.1038/LEU.2015.106
P577
2015-05-14T00:00:00Z
P6179
1005476792